Ampicillin and Sulbactam for Injection recalled nationwide for sterility assurance deficiency
Ampicillin and Sulbactam for Injection vials are being recalled nationwide due to lack of assurance of sterility. Approximately 91,860 vials of this prescription antibiotic have been affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II drug recall initiated due to lack of sterility assurance in an injectable antibiotic. No illnesses or injuries have been reported. The potential hazard of infection from a non-sterile injectable is serious but unconfirmed, placing this in the High severity category per the rubric criterion for risk-of-harm products where injury has not yet been reported.
Plain-English summary
Ampicillin and Sulbactam for Injection, USP (3 grams per vial), is being recalled nationwide. This is a prescription injectable antibiotic manufactured by Astral SteriTech Private Ltd. for Piramal Critical Care, located in Bethlehem, Pennsylvania. Approximately 91,860 vials are included in the recall and were distributed throughout the United States.
The recall was initiated due to lack of assurance of sterility. All lot numbers of the affected product are currently within their expiration dates.
Healthcare facilities, pharmacies, prescribers, and patients in possession of this product should immediately discontinue use and quarantine all affected vials. Contact the manufacturer or the U.S. Food and Drug Administration for guidance on replacement products and proper handling of recalled inventory.
The recalled product
- Product
- Ampicillin and Sulbactam for Injection, USP 3 grams vials, Rx only, Mfg. for: Piramal Critical Care, Bethlehem, PA 18017 USA, NDC 66794-242-41
- Manufacturer
- Astral SteriTech Private Ltd.
- Category
- Drug — Injectable Antibiotic
- Hazard
- lack-of-sterility
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27